Undiagnosed Diseases Network Solves Ocular Syndromic Diagnostic Dilemmas

The Undiagnosed Diseases Network (UDN), a multicenter initiative funded by the National Institutes of Health (NIH), has made significant progress in diagnosing puzzling ocular disorders. This research, conducted by Vanderbilt University Medical Center, highlights the network's assistance in solving complex cases through advanced genomic technologies.

Key Takeaways:

• The UDN has a national diagnostic rate of 40.2% for subjects with an eye phenotype, significantly higher than the 27.8% diagnostic rate for those without an eye phenotype.
• In univariate analysis, having an eye phenotype was significantly associated with receiving a diagnosis, with an odds ratio of 1.75 (CI = 1.45-2.10; P = 2.28e-09).
• The study presented six case illustrations of ocular disorders diagnosed by the UDN, including a rare de novo variant in COG4 causing a cataract/ retinitis pigmentosa/ nystagmus phenotype, and a homozygous variant in NADK2 causing optic nerve atrophy.
• The UDN has collaborated with clinicians, including ophthalmologists, to solve challenging ocular mysteries using genomic technologies.
• The research emphasizes the importance of collaboration between clinicians and the UDN in improving care options for patients with undiagnosed diseases.

Statistics:

• The national UDN diagnostic rate for subjects with an eye phenotype was 40.2% (452 of 1123).
• The diagnostic rate for the other subjects (without an eye) phenotype was 27.8% (276 of 992).
• The odds ratio of receiving a diagnosis for subjects with an eye phenotype was 1.75 (CI = 1.45-2.10).
• The P-value for the association between having an eye phenotype and receiving a diagnosis was 2.28e-09.

Sources:

• The Undiagnosed Diseases Network (UDN) Solves Ocular Syndromic Diagnostic Dilemmas. American Journal of Ophthalmology, 2025;280:51-63.
• VerticalNews. "New Research on Genomics and Genetics Described." Journal of Engineering, September 15, 2025, p 3414.